These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33820581)

  • 1. Rollout of COVID-19 Vaccination in India: A SWOT Analysis.
    Sharma P; Pardeshi G
    Disaster Med Public Health Prep; 2021 Apr; ():1-4. PubMed ID: 33820581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the COVID-19 Vaccination Rollout in 17 Countries: Reflexive Thematic and Frequency Analysis Based on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) Framework.
    Kopilaš V; Nasadiuk K; Martinelli L; Lhotska L; Todorovic Z; Vidmar M; Machado H; Svalastog AL; Gajović S
    JMIR Hum Factors; 2024 Feb; 11():e44258. PubMed ID: 38373020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SWOT analysis of influenza vaccination promotion of primary care staff based on the perspective of the supplier, customer, and management].
    Sun B; Zheng JD; Zhang SY; Lu MX; Yuan H; Wang JR; Li JC; Su JF; Li M; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):953-959. PubMed ID: 35725355
    [No Abstract]   [Full Text] [Related]  

  • 4. Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports.
    Basu S; Sharma H
    Cureus; 2023 Mar; 15(3):e36750. PubMed ID: 37123709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
    Ramezanpour B; Pronker ES; Kreijtz JH; Osterhaus AD; Claassen E
    Vaccine; 2015 Aug; 33(35):4349-58. PubMed ID: 26048779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community voices around COVID-19 vaccine in Chennai, India: A qualitative exploration during early phase of vaccine rollout.
    Kumar MS; Madhumathi J; Gayathri K; A Rozario AG; Vijayaprabha R; Balusamy M; Sonekar H; Panda S
    Indian J Med Res; 2022; 155(5&6):451-460. PubMed ID: 35975352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease-2019 risk management using strengths, weaknesses, opportunities, threats analysis approach in the health system: A qualitative multimethod study.
    Bazyar J; Alimoradi S; Seydi M; Pourvakhshoori N; Sadeghifar J
    J Educ Health Promot; 2021; 10():453. PubMed ID: 35233400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the Programme.
    Murewanhema G; Musuka G; Denhere K; Chingombe I; Mapingure MP; Dzinamarira T
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SWOT analysis: strengths, weaknesses, opportunities and threats of the Israeli Smallpox Revaccination Program.
    Huerta M; Balicer RD; Leventhal A
    Isr Med Assoc J; 2003 Jan; 5(1):42-6. PubMed ID: 12592958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long road of pandemic vaccine development to rollout: A systematic review on the lessons learnt from the 2009 H1N1 influenza pandemic.
    Ankomah AA; Moa A; Chughtai AA
    Am J Infect Control; 2022 Jul; 50(7):735-742. PubMed ID: 35131349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.
    Sadler SJ; Torio EF; Golby AJ
    Cancer; 2023 Mar; 129(5):671-684. PubMed ID: 36597652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.
    Godbole S; Diwan V; Das S; Reddy MM; Kalyanasundaram M; Rajendran D; Biswas D; Mamulwar M; Tiwari RR; Majumder J; Mishra A; Muthusamy SK; Memeenao M; Gupta N; Gupta S; George LS; Kadale P; Trushna T; Saha I; Alam U; Kathiresan J; Phukan SK; Sane S; Bhowmik K; Yadav GK; Krishnamurthy V; Gogoi P; Padhye K; Kant R; Ghosh P; Kharat M; Kulkarni A
    Front Public Health; 2023; 11():1293600. PubMed ID: 38328539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social media sentiment analysis to monitor the performance of vaccination coverage during the early phase of the national COVID-19 vaccine rollout.
    Rahmanti AR; Chien CH; Nursetyo AA; Husnayain A; Wiratama BS; Fuad A; Yang HC; Li YJ
    Comput Methods Programs Biomed; 2022 Jun; 221():106838. PubMed ID: 35567863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The voluntary community health movement in India: a strengths, weaknesses, opportunities, and threats (SWOT) analysis.
    Sharma M; Bhatia G
    J Community Health; 1996 Dec; 21(6):453-64. PubMed ID: 8912121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic Modeling.
    Huangfu L; Mo Y; Zhang P; Zeng DD; He S
    J Med Internet Res; 2022 Feb; 24(2):e31726. PubMed ID: 34783665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Challenges of Digital Health Interventions in Pakistan: Mixed Methods Analysis.
    Kazi AM; Qazi SA; Ahsan N; Khawaja S; Sameen F; Saqib M; Khan Mughal MA; Wajidali Z; Ali S; Ahmed RM; Kalimuddin H; Rauf Y; Mahmood F; Zafar S; Abbasi TA; Khoumbati KU; Abbasi MA; Stergioulas LK
    J Med Internet Res; 2020 Sep; 22(9):e21691. PubMed ID: 32880584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWOT Analysis and Recommendations for Community Health Workers and Stakeholders Responding to COVID-19 Health Inequities.
    Zoschke IN; Betancur A; Ehsan S; TenHaken JD; Rahman JR; King-Tezino K; Kramer-Najjar M; Bravo CA; Wilkerson JM
    Health Promot Pract; 2023 Oct; ():15248399231201131. PubMed ID: 37846742
    [No Abstract]   [Full Text] [Related]  

  • 19. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.